Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study

Inclusion Criteria

• •≥ 18 years of age at the time of consent.
• •Must be able to speak, read, and understand English.
• •Participants diagnosed with NSCLC, and:
• •* have advanced/metastatic disease who are currently receiving immunotherapy monotherapy, or
• •* have locally advanced disease who are currently receiving immunotherapy monotherapy after completing thoracic radiation therapy, or
• •* who underwent resection and are currently receiving immunotherapy monotherapy after completing all other perioperative treatment
• •Immunotherapy planned to continue for at least three months after the time of study enrollment (to ensure participant remains on IO long enough to obtain study assessments)
• •Have completed at least two cycles of immunotherapy.
• •Self-reported cancer-related fatigued that impacts daily function.